Safety and immunogenicity of SpiN-Tec, a T-cell based RBD-Nucleocapsid chimeric vaccine for COVID-19.

Safety and immunogenicity of SpiN-Tec, a T-cell based RBD-Nucleocapsid chimeric vaccine for COVID-19.

Publication date: Sep 19, 2025

Concepts Keywords
100g Ba
Biontech Based
Cd4 Booster
Thirty Chimeric
Vaccinated Covid
Covishield
Immunogenicity
Nucleocapsid
Rbd
Safety
Showed
Spin
Tec
Vaccine

Semantics

Type Source Name
disease IDO cell
disease MESH COVID-19
disease IDO protein
drug DRUGBANK Squalene
disease IDO production
disease IDO immune response

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *